Kenneth C. Phillippe
Biochemistry
Advanced Proteome Therapeutics
Canada
Biography
Mr. Phillippe is a Chartered Accountant with over 25 years’ experience working with public companies in the capacities of director, officer, financial advisor or consultant. Mr. Phillippe obtained a Bachelor of Commerce degree from the University of British Columbia in 1976. He articled with Thorne Riddell (now KPMG) and in1982 established his own accounting practice. During the period from February, 2000 to 2008, Mr. Phillippe held several high level Executive positions including director, officer, and chair of the audit committee of Urodynamix Technologies Ltd. (TSX – (URO.V))., CFO of Columbia Goldfields Ltd. (TSX – (GOL.TO) / OTCBB –(CGDF)), as Secretary, Treasurer, CFO and Principal Accounting Officer of Amazon Goldsands Ltd.(OTCBB – (AZNG)), as well as Constitution Mining Corp (OTCC – (CMIN)). Since 2006, Mr. Phillippe has served as Chief Financial Officer of Exchequer Resource Corp. (TSX/NEX – (EXQ.H)) as well as Chief Financial Officer and Secretary of Bold Ventures Inc. (TSX – (BOL.V)). Mr. Phillippe is a Chartered Accountant with over 25 years’ experience working with public companies in the capacities of director, officer, financial advisor or consultant. Mr. Phillippe obtained a Bachelor of Commerce degree from the University of British Columbia in 1976. He articled with Thorne Riddell (now KPMG) and in1982 established his own accounting practice. During the period from February, 2000 to 2008, Mr. Phillippe held several high level Executive positions including director, officer, and chair of the audit committee of Urodynamix Technologies Ltd. (TSX – (URO.V))., CFO of Columbia Goldfields Ltd. (TSX – (GOL.TO) / OTCBB –(CGDF)), as Secretary, Treasurer, CFO and Principal Accounting Officer of Amazon Goldsands Ltd.(OTCBB – (AZNG)), as well as Constitution Mining Corp (OTCC – (CMIN)). Since 2006, Mr. Phillippe has served as Chief Financial Officer of Exchequer Resource Corp. (TSX/NEX – (EXQ.H)) as well as Chief Financial Officer and Secretary of Bold Ventures Inc. (TSX – (BOL.V)).
Research Interest
Biochemistry
